Business & Consumer Services » Consumer Services | Rasna Therapeutics Inc.

Rasna Therapeutics Inc. | Balance Sheet

Fiscal year is July-June. All values USD Thousands.
2013
2014
2015
2016
Cash & Short Term Investments
46.30
6.30
0.00
0.10
Total Current Assets
46.30
6.30
0.00
0.10
Other Assets
-
0.40
0.40
0.10
Total Assets
46.30
6.70
0.40
0.30
ST Debt & Current Portion LT Debt
-
-
-
18.80
Other Current Liabilities
0.60
1.00
11.40
53.80
Total Current Liabilities
0.60
1.00
11.40
72.60
Total Liabilities
0.60
1.00
11.40
72.60
Common Equity (Total)
45.70
5.70
11.10
72.30
Total Shareholders' Equity
45.70
5.70
11.10
72.30
Total Equity
45.70
5.70
11.10
72.30
Liabilities & Shareholders' Equity
46.30
6.70
0.40
0.30

About Rasna Therapeutics

View Profile
Address
420 Lexington Avenue
New York New York 10170
United States
Employees -
Website http://www.rasna.com
Updated 07/08/2019
Rasna Therapeutics, Inc. engages in the provision of medical development. Its activities include research and development of treatment for leukemia and other cancers. It involves in modulating the molecular targets NPM1 and LSD1, which are implicated in the disease progression of leukemia and lymphoma.